SEARCH

SEARCH BY CITATION

References

  • Bergstrand IC, Heijl A & Harris A (2002): Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study. Acta Ophthalmol Scand 80: 176182.
  • Bergstrand IC, Heijl A, Wollmer P, Hansen F & Harris A (2001): Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension. Acta Ophthalmol Scand 79: 455461.
  • Burke J & Schwartz M (1996): Preclinical evaluation of brimonidine. Surv Ophthalmol 41: S9S18.
  • Camras CB (1995): Clinical applications of α2-adrenergic agonist in ophthalmology. J Glaucoma 4: S30S35.
  • Camras CB, Alm A, Watson P & Stjernschantz J (1996): Latanoprost, a prostaglandin analogue, for glaucoma therapy. Ophthalmology 103: 19161924.
  • Carenini BB, Brogliatti B, Carenini AB, Sibour G & Demarie G (1993): Ischaemia and glaucoma. New Trends Ophthalmol 8: 7580.
  • Carlson AM, Chauhan BC, Lee AA & LeBlanc RP (2000): The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. Am J Ophthalmol 129: 297301.
  • Chung HS, Harris A & Evans D (1999): Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol 43: S43S50.
  • Drance SM, Crichton A & Mills RP (1998): Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal tension glaucoma. Am J Ophthalmol 125: 585592.
  • Georgopoulos GT, Diestelhorst M, Fisher R, Ruokomen P & Krieglstein GK (2002): The short-term effects of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta Ophthalmol Scand 80: 5458.
  • Geyer O, Man O, Weintraub M & Silver DM (2001): Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol 131: 198202.
  • Graham SL, Drance SM, Wijsman K, Douglas GR & Mikelberg FS (1995): Ambulatory blood pressure monitoring in glaucoma: the nocturnal dip. Ophthalmology 102: 6169.
  • Greve EL, Rulo AH, Drance SM, Crichton AC, Mills RP & Hoyng PFJ (1997): Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimes of latanoprost treatment. Surv Ophthalmol 41 (Suppl 2): 8992.
  • Grienfield DS, Liebman JM & Ritch R (1997): Brimonidine: a new α2-adrenoreceptor agonist for glaucoma treatment. J Glaucoma 6: 250258.
  • Harris A, Arend O, Chung HS, Kagemann L, Cantor L & Martin B (2000): A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal tension glaucoma patients. Ophthalmology 107: 430434.
  • Harris A, Joos K & Kay M (1996): Acute IOP elevation with scleral suction: effects on retrobulbar haemodynamics. Br J Ophthalmol 80: 15.
  • Harris A, Spaeth GL, Sergott RC, Katz LJ, Cantor LB & Martin BJ (1995): Retrobulbar arterial haemodynamic effects of betaxolol and timolol in normal tension glaucoma. Am J Ophthalmol 120: 168175.
  • Ishii K, Tomidokoro A, Nagahara M, Tamaki Y, Kanno M, Fukaya Y & Araie M (2001): Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 42: 29572963.
  • Jonescu-Cuypers CP, Harris A & Ishii Y (2001): Effect of brimonidine tartrate on ocular haemodynamics in healthy volunteers. J Ocul Pharmacol Ther 17: 199205.
  • Joos KM, Kay MD & Pillunat LE (1999): The effect of acute intraocular pressure changes on short posterior ciliary artery haemodynamics. Br J Ophthalmol 83: 3338.
  • Kaiser HJ, Schoetzau A, Stümpfig D & Flammer J (1997): Blood-flow velocities of the extraocular vessels in patients with high tension and normal tension primary open-angle glaucoma. Am J Ophthalmol 123: 320327.
  • Kjellgren D, Douglas G, Mikelberg FS, Drance SM & Alm A (1995): The short time effect of latanoprost on the intraocular pressure in normal pressure glaucoma. Acta Ophthalmol Scand 73: 233236.
  • Lachkar Y, Migdal C & Dhanjil S (1998): Effect of brimonidine tartrate on ocular haemodynamic measurements. Arch Ophthalmol 116: 15911594.
  • Marcello TN, Peter H, Stephan MD, Nicolea MT, Hnik P & Drance SM (1996): Scanning laser Doppler flowmeter study of retinal and optic disc blood flow in glaucomatous patients. Am J Ophthalmol 122: 775783.
  • McKibbin M & Menage MJ (1999): The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 13: 3134.
  • Nicolea MT, Buckley AR, Walman BE & Drance SM (1996a): A comparative study of the effects of timolol and latanoprost on blood flow velocity of retrobulbar vessels. Am J Ophthalmol 122: 784789.
  • Nicolea MT, Walman BE, Buckley AR & Drance SM (1996b): Various glaucomatous optic nerve appearances. A colour Doppler imaging study of retrobulbar circulation. Ophthalmology 103: 16701679.
  • Nordlund JR, Pasquale LR & Robin AL (1995): The cardiovascular, pulmonary and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol 113: 7783.
  • Robert D, Steigerwalt JR, Belcaro GV & Giuseppe L (1998): Ocular and orbital blood flow in patients with essential hypertension treated with trandolapril. Retina 18: 539545.
  • Schuman JS (1996): Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 41: S27S37.
  • Seong GJ, Lee HK & Hong YJ (1999): Effects of 0.005% latanoprost optic nerve head and peripapillary retinal blood flow. Ophthalmologica 213: 355359.
  • Stjernschantz J, Selen G, Astin M, Karlsson M & Resul B (1999): Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye. Arch Ophthalmol 117: 13631367.
  • Tamaki Y, Nagahara M, Araie M, Tomita K, Sandoh S & Tomidokoro A (2001): Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther 17: 403411.
  • Vetrugno M, Cantatore F, Gigante G & Cardia L (1998): Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow. Acta Ophthalmol Scand 227: 4041.
  • Vetrugno M, Maino A, Cantatore F, Ruggeri G & Cardia L (2001): Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study. Clin Ther 23: 15191528.
  • Walters TR (1996): Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose–response and dosing studies. Surv Ophthalmol 41: S19S26.
  • Wilensky JT (1996): The role of brimonidine in the treatment of open-angle glaucoma. Surv Ophthalmol 41 (Suppl): 37.